Cancer risk in collagenous colitis.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 10028448)

Published in Inflamm Bowel Dis on February 01, 1999

Authors

J L Chan1, A C Tersmette, G J Offerhaus, S B Gruber, T M Bayless, F M Giardiello

Author Affiliations

1: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Articles citing this

Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol (2009) 1.30

Diagnosis and management of microscopic colitis. World J Gastroenterol (2008) 1.24

Complications of collagenous colitis. World J Gastroenterol (2008) 1.13

Resolution of paraneoplastic collagenous enterocolitis after resection of colon cancer. Can J Gastroenterol (2006) 1.06

Microscopic colitis: Common cause of unexplained nonbloody diarrhea. World J Gastrointest Pathophysiol (2014) 1.00

Evolution of collagenous colitis into severe and extensive ulcerative colitis. Can J Gastroenterol (2007) 0.94

Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management-an update 2013. ISRN Gastroenterol (2013) 0.92

Decreased colorectal cancer and adenoma risk in patients with microscopic colitis. Dig Dis Sci (2011) 0.84

Recent advances in diagnosis and treatment of microscopic colitis. Ann Gastroenterol (2011) 0.84

Long-term natural history and complications of collagenous colitis. Can J Gastroenterol (2012) 0.81

Microscopic colitis. World J Gastroenterol (2012) 0.81

Microscopic colitis: a review for the surgical endoscopist. Can J Surg (2009) 0.78

Diagnosis and Management of Microscopic Colitis. Am J Gastroenterol (2016) 0.76

Latent lymphocytic enterocolitis associated with celiac disease manifesting after resection for colon cancer: case report and review of the literature. Can J Gastroenterol (2008) 0.75

Acute surgical abdomen in collagenous colitis. Gastroenterol Hepatol (N Y) (2013) 0.75

Selected luminal mucosal complications of adult celiac disease. Clin Exp Gastroenterol (2009) 0.75

New insights and challenges in microscopic colitis. Therap Adv Gastroenterol (2015) 0.75

Articles by these authors

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13

Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86

Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55

Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07

Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet (1994) 3.69

The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology (1992) 3.59

K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56

Preliminary evidence for genetic anticipation in Crohn's disease. Lancet (1996) 3.32

Experimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies. Nat Genet (2001) 3.20

Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol (1989) 3.02

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02

Intestinal ulceration--a complication of celiac disease. N Engl J Med (1967) 2.90

Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A (1998) 2.88

Collagenous colitis with mucosal tears on endoscopic insufflation: a unique presentation. Gut (2002) 2.81

Inhibition of apoptosis during development of colorectal cancer. Cancer Res (1995) 2.77

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67

Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology (1991) 2.55

Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology (1996) 2.50

Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29

Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23

The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet (2004) 2.10

Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08

Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther (2014) 2.04

Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98

Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology (1992) 1.98

Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Pathol (1987) 1.97

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am J Pathol (2001) 1.95

Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol (1993) 1.91

Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88

The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology (1995) 1.86

Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86

Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut (1998) 1.85

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85

Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81

Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79

The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77

Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76

Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg (1980) 1.75

Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion (1989) 1.73

Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73

Leptin is a growth factor for colonic epithelial cells. Gastroenterology (2001) 1.71

American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. Gastroenterology (1998) 1.71

A racial difference in incidence of lactase deficiency. A survey of milk intolerance and lactase deficiency in healthy adult males. JAMA (1966) 1.70

Decreased expression of the gut-enriched Krüppel-like factor gene in intestinal adenomas of multiple intestinal neoplasia mice and in colonic adenomas of familial adenomatous polyposis patients. FEBS Lett (2000) 1.70

Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69

Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterology (1988) 1.67

Is physician detection associated with thinner melanomas? JAMA (1999) 1.66

Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci (1989) 1.65

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst (1991) 1.64

Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression. Thromb Haemost (2000) 1.63

Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol (2001) 1.61

Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy (2007) 1.60

Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol (1994) 1.59

Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut (1999) 1.59

K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer (1993) 1.57

Collagenous colitis in setting of nonsteroidal antiinflammatory drugs and antibiotics. Dig Dis Sci (1990) 1.56

The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol (1998) 1.56

Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines. Br J Cancer (2004) 1.54

Clinical manifestations of Crohn's disease in children and adolescents. Pediatrics (1975) 1.52

Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51

Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A (1994) 1.50

Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50

Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50

Fructose: incomplete intestinal absorption in humans. Gastroenterology (1983) 1.48

Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet (1999) 1.46

Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol (2000) 1.44

A patient with seven primary tumors of the upper aerodigestive tract: the process of field cancerization versus distant monoclonal expansion. Dis Esophagus (1997) 1.43

Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut (2006) 1.42

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol (1998) 1.42

Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis. Gut (2008) 1.41

Breath hydrogen testing as a physiology laboratory exercise for medical students. Am J Physiol (1992) 1.40

Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity. Gastroenterology (2000) 1.40

Favorable response to parenteral nutrition and medical therapy in Crohn's colitis. A report of 38 patients comparing severe Crohn's and ulcerative colitis. Gastroenterology (1990) 1.39

A filing system for the gastroenterology/hepatology consultant. Am J Gastroenterol (1995) 1.39

Geographical variance in the risk of gastric stump cancer: no increased risk in Japan? Jpn J Cancer Res (1991) 1.39

[Barrett esophagus and Barrett carcinoma]. Ned Tijdschr Geneeskd (1997) 1.39

Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat (1999) 1.39

Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. J Clin Invest (1980) 1.38

Digestion: intestinal secretion. Annu Rev Physiol (1970) 1.37

Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol (2002) 1.34

Familial pancreatic cancer. Ann Oncol (1999) 1.33